newsfilter
← Latest News
GlobeNewswire·

Korro to Present at the 2026 Jefferies Global Healthcare Conference in London

CAMBRIDGE, Mass., Nov. 06, 2026 (GLOBE NEWSWIRE) -- Korro Bio, Inc. (Korro) (NASDAQ:KRRO), a clinical-stage biopharmaceutical company leveraging a novel Oligonucleotide Promoted Editing of RNA (OPERA®) platform to